141 related articles for article (PubMed ID: 33357178)
1. Facile Synthesis of Boc-Protected Selenocystine and its Compatibility with Late-Stage Farnesylation at Cysteine Site.
Zhu PC; Chen YX
Protein Pept Lett; 2021; 28(6):603-611. PubMed ID: 33357178
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of membrane binding of small GTPase K-Ras4B farnesylated hypervariable region.
Jang H; Abraham SJ; Chavan TS; Hitchinson B; Khavrutskii L; Tarasova NI; Nussinov R; Gaponenko V
J Biol Chem; 2015 Apr; 290(15):9465-77. PubMed ID: 25713064
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of selenopeptides: an alternative way of incorporating selenocystine.
Aravindhan S; Singh HB; Zeller M; Butcher RJ
Amino Acids; 2019 Apr; 51(4):661-667. PubMed ID: 30798465
[TBL] [Abstract][Full Text] [Related]
4. Flexible-body motions of calmodulin and the farnesylated hypervariable region yield a high-affinity interaction enabling K-Ras4B membrane extraction.
Jang H; Banerjee A; Chavan T; Gaponenko V; Nussinov R
J Biol Chem; 2017 Jul; 292(30):12544-12559. PubMed ID: 28623230
[TBL] [Abstract][Full Text] [Related]
5. GTP Binding and Oncogenic Mutations May Attenuate Hypervariable Region (HVR)-Catalytic Domain Interactions in Small GTPase K-Ras4B, Exposing the Effector Binding Site.
Lu S; Banerjee A; Jang H; Zhang J; Gaponenko V; Nussinov R
J Biol Chem; 2015 Nov; 290(48):28887-900. PubMed ID: 26453300
[TBL] [Abstract][Full Text] [Related]
6. One-Pot Ligation-Oxidative Deselenization at Selenocysteine and Selenocystine.
Mitchell NJ; Kulkarni SS; Malins LR; Wang S; Payne RJ
Chemistry; 2017 Jan; 23(4):946-952. PubMed ID: 27859731
[TBL] [Abstract][Full Text] [Related]
7. Characterization of (Boc-Cys/Sec-NHMe)
Dolle A; Reddy KKA; Gunaga SS; Krishnamurthy K; Senapati DK; Rana A; Sindogi K; Biswal HS; Raghothama S; Gowd KH
J Pept Sci; 2020 Apr; 26(4-5):e3245. PubMed ID: 32103604
[TBL] [Abstract][Full Text] [Related]
8. Synthetic study on selenocystine-containing peptides.
Koide T; Itoh H; Otaka A; Yasui H; Kuroda M; Esaki N; Soda K; Fujii N
Chem Pharm Bull (Tokyo); 1993 Mar; 41(3):502-6. PubMed ID: 8477500
[TBL] [Abstract][Full Text] [Related]
9. The higher level of complexity of K-Ras4B activation at the membrane.
Jang H; Banerjee A; Chavan TS; Lu S; Zhang J; Gaponenko V; Nussinov R
FASEB J; 2016 Apr; 30(4):1643-55. PubMed ID: 26718888
[TBL] [Abstract][Full Text] [Related]
10. The Hypervariable Region of K-Ras4B Governs Molecular Recognition and Function.
Abdelkarim H; Banerjee A; Grudzien P; Leschinsky N; Abushaer M; Gaponenko V
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739603
[TBL] [Abstract][Full Text] [Related]
11. Lipid-binding characteristics of the polybasic carboxy-terminal sequence of K-ras4B.
Leventis R; Silvius JR
Biochemistry; 1998 May; 37(20):7640-8. PubMed ID: 9585579
[TBL] [Abstract][Full Text] [Related]
12. Markov State Models and Molecular Dynamics Simulations Reveal the Conformational Transition of the Intrinsically Disordered Hypervariable Region of K-Ras4B to the Ordered Conformation.
Zhang H; Ni D; Fan J; Li M; Zhang J; Hua C; Nussinov R; Lu S
J Chem Inf Model; 2022 Sep; 62(17):4222-4231. PubMed ID: 35994329
[TBL] [Abstract][Full Text] [Related]
13. Rapid additive-free selenocystine-selenoester peptide ligation.
Mitchell NJ; Malins LR; Liu X; Thompson RE; Chan B; Radom L; Payne RJ
J Am Chem Soc; 2015 Nov; 137(44):14011-4. PubMed ID: 26487084
[TBL] [Abstract][Full Text] [Related]
14. K-Ras4B lipoprotein synthesis: biochemical characterization, functional properties, and dimer formation.
Dementiev A
Protein Expr Purif; 2012 Jul; 84(1):86-93. PubMed ID: 22569482
[TBL] [Abstract][Full Text] [Related]
15. The hypervariable region of K-Ras4B is responsible for its specific interactions with calmodulin.
Abraham SJ; Nolet RP; Calvert RJ; Anderson LM; Gaponenko V
Biochemistry; 2009 Aug; 48(32):7575-83. PubMed ID: 19583261
[TBL] [Abstract][Full Text] [Related]
16. High-Affinity Interaction of the K-Ras4B Hypervariable Region with the Ras Active Site.
Chavan TS; Jang H; Khavrutskii L; Abraham SJ; Banerjee A; Freed BC; Johannessen L; Tarasov SG; Gaponenko V; Nussinov R; Tarasova NI
Biophys J; 2015 Dec; 109(12):2602-2613. PubMed ID: 26682817
[TBL] [Abstract][Full Text] [Related]
17. High affinity for farnesyltransferase and alternative prenylation contribute individually to K-Ras4B resistance to farnesyltransferase inhibitors.
Fiordalisi JJ; Johnson RL; Weinbaum CA; Sakabe K; Chen Z; Casey PJ; Cox AD
J Biol Chem; 2003 Oct; 278(43):41718-27. PubMed ID: 12882980
[TBL] [Abstract][Full Text] [Related]
18. No selenium required: reactions catalyzed by mammalian thioredoxin reductase that are independent of a selenocysteine residue.
Lothrop AP; Ruggles EL; Hondal RJ
Biochemistry; 2009 Jul; 48(26):6213-23. PubMed ID: 19366212
[TBL] [Abstract][Full Text] [Related]
19. A mechanistic investigation of the C-terminal redox motif of thioredoxin reductase from Plasmodium falciparum.
Snider GW; Dustin CM; Ruggles EL; Hondal RJ
Biochemistry; 2014 Jan; 53(3):601-9. PubMed ID: 24400600
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Ha-ras, N-ras, Ki-Ras4A, and Ki-Ras4B as in vitro substrates for farnesyl protein transferase and geranylgeranyl protein transferase type I.
Zhang FL; Kirschmeier P; Carr D; James L; Bond RW; Wang L; Patton R; Windsor WT; Syto R; Zhang R; Bishop WR
J Biol Chem; 1997 Apr; 272(15):10232-9. PubMed ID: 9092572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
